Health

Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study Findings

PERTH, Australia, Sept. 26, 2024 /PRNewswire/ -- A groundbreaking study published inClinical Obesity reveals that providing personalised energy expenditure data significantly improves weight loss outcomes in individuals with obesity1 . Condu...

2024-09-26 08:11 1702

Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis

SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewedstudy validating its innovative method for measuring central aortic pressure...

2024-09-26 07:15 1525

Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care

The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules SALT LAKE CITY and NASHVILLE, Tenn., Sept. 25, 2024 /PRNewswir...

2024-09-25 22:02 2084

Shin-Etsu SE Tylose and LBB Specialties Announce Distribution Partnership for Cellulose Pharma Excipients in North and Central America

NORWALK, Conn., Sept. 25, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution inNorth America, announces a new partnership with SE TyloseUSA for cellulose excipients in the Pharma Excipients and Nutra Ingredients markets. EffectiveNovember 1, 2...

2024-09-25 22:00 1453

Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC Regulatory Harmonization Steering Committee

PHILADELPHIA, Sept. 25, 2024 /PRNewswire/ -- Rx-360® is pleased to announce that it has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global Medical Product Supply Chain Integrity Priority Work Area R...

2024-09-25 21:09 1557

SI GROUP ANNOUNCES PLANS TO CLOSE MANUFACTURING SITE IN SINGAPORE

Company plans to cease manufacturing operations in second half of 2025 due to declining market conditions THE WOODLANDS, Texas, Sept. 25, 2024 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermedi...

2024-09-25 20:00 1852

CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean - Decentralised Approach Serves the Needs of the Caribbean Community

HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ -- CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed's Xceler8 Platform across theCaribbean. Implementing this cutting-edge technology in the region marks a major advancement in the field ofCaribbean ge...

2024-09-25 19:00 1571

New Research from the International Coaching Federation Highlights Trends in Workplace Burnout

 - Demand for mental well-being support becoming widespread - LEXINGTON, Ky., Sept. 25, 2024 /PRNewswire/ -- New research, released today by the International Coaching Federation (ICF), indicates growing workplace demand for mental well-being support. With mental well health concerns including b...

2024-09-25 17:00 1435

GSK's Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia

* Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV * Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy observed in adults with co-morbidities vii KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire...

2024-09-25 16:45 1737

FONDAZIONE PRADA PRESENTS "PRESERVING THE BRAIN: A CALL TO ACTION" IN MILAN

MILAN, Sept. 25, 2024 /PRNewswire/ -- The new edition of "Preserving the Brain," part of Fondazione Prada's "Human Brains" project dedicated to neurosciences since 2018, will focus on the prevention of neurodegenerative diseases. Organized in partnership with fifteen renowned neuroscience instit...

2024-09-25 16:00 1287

Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies

* Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach. SHANGHAI, Sept. 25, 2024 /PRNewswire/ -- Belief BioMed Inc. (BBM), a biotech company focusing on innovative gene therapies, today announce...

2024-09-25 14:58 1454

Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024

* Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports interchangeability between adalimumab and adalimumab-fkjp * Biosimilarity between Bmab 1200 and reference biologic-Ustekinumab in pivotal Phase 3 trial in patients with moder...

2024-09-25 13:21 1281

Get To Know Severe Asthma: The Chronic, Life-Threatening Condition Affecting 7-11% Adults In Asian Countries

KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire/ -- Asthma is well-known as a common respiratory condition. But did you know that there exists a life-threatening type of the condition calledsevere asthma, that requires specialised, multidisciplinary treatment to manage? Severe asthma is estim...

2024-09-25 11:00 1466

G7 DFIs, MedAccess, EIB, and IFC Announce MoU for Surge Financing Initiative for Medical Countermeasures

Media Kit: DFC at UNGA 2024 NEW YORK, Sept. 25, 2024 /PRNewswire/ -- Today, participating G7 development finance institutions (DFIs), MedAccess, the European Investment Bank (EIB), and the International Finance Corporation (IFC) announced the signing of a memorandum of understanding (MoU) for th...

2024-09-25 06:44 1219

EADV Congress 2024: Semaglutide improves outcomes for obese patients with common skin condition, new study shows

A pioneering study, presented today at the EADV Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity. AMSTERDAM, Sept. 25, 2024 /PRNewswire/ -- This is the first study to explore...

2024-09-25 06:01 1339

Everise Signs Agreement to Acquire Continuum Global Solutions' Healthcare Vertical

The acquisition strengthens the foundation for Everise as an end-to-end healthcare experience provider PLANTATION, Fla., Sept. 25, 2024 /PRNewswire/ -- Global healthcare customer experience company Everise today announced that it has signed a binding agreement to acquire the healthcare vertical ...

2024-09-25 02:26 5051

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

ADELAIDE, South Australia, Sept. 24, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug developer EnGeneIC Pty Ltd., for a project including technology transfer, process scale-up an...

2024-09-24 23:37 2021

Maybelline New York Launches a New 5-Step Routine - and It Doesn't Include Makeup.

Brave Talk, a new online, five-step training program, empowers young people to navigate mental health conversations with their friends.  NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Maybelline New York announced today the expansion of its free global mental health training program,Brave Talk. Initi...

2024-09-24 21:00 1437

Eyebright Medical Continues to Employ Its Internationalization Strategy: Signed Memorandum with Invest Hong Kong and Spotlight at ESCRS 2024

HONG KONG, Sept. 24, 2024 /PRNewswire/ -- Eyebright Medical Technology (Beijing ) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively known as the "Group") is pleased to announce the recently development of its internationalization stra...

2024-09-24 20:00 1708

Huawei Calls to Expand Partnerships to Drive Global Digital Inclusion through TECH4ALL

SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- At the TECH4ALL Digital Inclusion Forum hosted at Huawei Connect 2024 , Huawei called for more partners to join its TECH4LL initiative to drive global digital inclusion.

2024-09-24 16:01 1453
1 ... 16171819202122 ... 580